Monday, August 26, 2013

Stocks DD Cites: Taro Pharma is the Number 1 Generic Dermatology Firm in the USA


Read, understand and consent to the blog's DISCLAIMER here before proceeding to read the article

Yes, It is official! Buried down under in a filing late last week, Taro, nonchalantly confirmed that it is now the Number 1 Generic Dermatology firm in the USA in Sales. Shareholders it is time to celebrate and be proud of this. You own an unique, invaluable asset in the market place: A Market Leader in a fundamentally favorable, limited competition business. 

No comments:

Post a Comment